Clinical Trial Update: Use of Gocovri to Improve Disability Due to Radiation Encephalopathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Gocovri (amantadine extended-release) for disability due to radiation encephalopathy; status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radiation Encephalopathy

Drugs mentioned

• Gocovri (amantadine extended-release)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Radiation Encephalopathy | Phase 2 | Status: NOT_YET_RECRUITING